Johnson & Johnson JNJ
$266.84
-1.37%
at last close
Market Cap$651.32 billion
P/E Ratio—
Div Yield2.01%
Volume3.06M
52-Week Range
$179.80$282.01
Analyst Ratings
- Consensus
- Moderate Buy — 12 Buy · 7 Hold · 0 Sell (19 analysts)
- Avg. Price Target
- $270.11 (+1.2% upside)
Key Stats
- Today's Range
- $266.68 – $271.07
- 50-Day Range
- $245.17 – $282.01
- 52-Week Range
- $179.80 – $282.01
- Volume
- 3.06 million shs
- Average Volume
- 7.31 million shs
- Market Cap
- $651.32 billion
- P/E Ratio
- —
- Dividend Yield
- 2.01%
Dividend
- Dividend Yield
- 2.01%
- Annual Dividend
- $5.36
- Payout Ratio
- —
- Ex-Dividend Date
- 2026-11-24
Short Interest
- Short Interest
- 0.67%
- Days to Cover
- 3.33
About Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Related Stocks
Compare head-to-head: JNJ vs LLY·JNJ vs ABBV·JNJ vs ABT·JNJ vs PFE
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.